In the press: BIOTECH Insight Newsletter


Deutsche Börse reports key figures for the growth of the German biotechnology sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG.

According to the results of the Biotechnology Company Survey 2022 conducted by BIOCOM AG (Berlin), the turnover of the German biotechnology sector increased significantly even after deducting the revenues of BioNTech.

BIOTECH Insight is a free information service from Deutsche Börse launched in December 2021 in collaboration with BIOCOM AG. Generally, the newsletter covers news and in-depth reports on the German biotech sector as well as interviews with CEOs or industry opinion leaders, start-up portraits and background files.

The current issue includes headline results on key economic figures for the sector (based on the BIOCOM report “The German Biotechnology Industry 2021″), an interview with Joachim Kreuzburg, CEO of Sartorius, a dossier on the economic potential of ” bio-based industry”, news as well as profiles of start-ups, investors and relevant biotech sites.

“With BIOTECH Insight, we want to create more visibility for the development of this attractive technology sector, map trends and topics as well as relevant players – also beyond the healthcare sector”, explains Peter Fricke, Head of Sales in capital markets, Deutsche Börse AG. The approach.

The BIOTECH Insight newsletter is sent twice a year, subscription is possible at any time:

+++ Register now for BIOTECH Insight! +++


Comments are closed.